Axios Harris Poll 100: Pfizer, Moderna reputations soar post-vaccine

By Sam Baker | Axios | May 13, 2021

America’s affections have shifted away from the companies that helped us manage pandemic life and toward the vaccine manufacturers that are helping to end it.

Driving the news: Moderna and Pfizer shot up the ranks this year in the Axios/Harris 100, our annual survey of corporate reputations. Moderna is Americans’ third-favorite company this year, and Pfizer came in at seventh — up from No. 61 a year ago.

  • CVS climbed 13 spots since last year.
  • Yes, but: Johnson & Johnson isn’t getting the same bounce from its coronavirus vaccine. It fell four spots, slipping to No. 72 on this year’s list — considered a “good” but not “excellent” or “very good” corporate reputation.

Flashback: A year ago, when Americans were still sanitizing our groceries and figuring out how to live in a state of lockdown, Clorox was America’s favorite company. Instacart, Peloton and Zoom leapt onto the list for the first time in 2020.

  • None of those companies made the cut this year.